Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.59 |
| ▸ | MAOB | P27338 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | ATM | Q13315 | 2/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1531427 | 1.00 | MAPT (0.62) | MAPTSOS1MAOBALDH1A1LMNA | |
| SCHEMBL11049170 | 0.89 | MAPT (0.69) | MAPTSOS1MAOBALDH1A1LMNA | |
| SCHEMBL14935499 | 0.89 | MAPT (0.69) | MAPTSOS1MAOBALDH1A1LMNA | |
| SCHEMBL9978289 | 0.89 | MAPT (0.69) | MAPTSOS1MAOBALDH1A1LMNA | |
| SCHEMBL11296000 | 0.87 | MAPT (0.67) | MAPTSOS1MAOBALDH1A1LMNA | |
| SCHEMBL11299049 | 0.87 | MAPT (0.67) | MAPTSOS1MAOBALDH1A1LMNA | |
| SCHEMBL5440780 | 0.85 | SOS1 (0.71) | MAPTSOS1MAOBALDH1A1LMNA | |
| SCHEMBL2550458 | 0.85 | MAPT (0.55) | MAPTSOS1MAOBALDH1A1LMNA | |
| SCHEMBL5440784 | 0.85 | SOS1 (0.71) | MAPTSOS1MAOBALDH1A1LMNA | |
| SCHEMBL1578978 | 0.82 | MAPT (0.66) | MAPTSOS1MAOBALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10597314-B2 | Fatty acid biodispersant and methods of use | GENERAL ELECTRIC COMPANY (US) | 2020-03-24 | — | — | US | claimed |
| EP-2173670-B1 | METHOD FOR CONTROLLING MICROBIAL BIOFILM IN AQUEOUS SYSTEMS | GEN ELECTRIC (US) | 2017-08-16 | — | — | EP | claimed |
| US-20160280570-A1 | FATTY ACID BIODISPERSANT AND METHODS OF USE | BL TECHNOLOGIES, INC. | 2016-09-29 | — | — | US | claimed |
| EP-3071524-A1 | FATTY ACID BIODISPERSANT AND METHODS OF USE | General Electric Company (US) | 2016-09-28 | — | — | EP | claimed |
| US-8784659-B2 | Method for controlling microbial biofilm in aqueous systems | GENERAL ELECTRIC COMPANY (US) | 2014-07-22 | — | — | US | claimed |
| WO-2012021006-A3 | DOUBLE-LAYER METAL THIN FILM TYPE ELECTRIC POWER GENERATOR, AND INTEGRATED ELECTRIC POWER GENERATOR USING SAME | CHUN SUN JU (KR) | 2012-05-10 | — | — | WO | claimed |
| US-7935521-B2 | Methods and compositions for rapidly detecting and quantifying viable Legionella | PHIGENICS, LLC (US) | 2011-05-03 | — | — | US | claimed |
| US-20110052656-A1 | METHOD FOR CONTROLLING MICROBIAL BIOFILM IN AQUEOUS SYSTEMS | GENERAL ELECTRIC COMPANY (US) | 2011-03-03 | — | — | US | claimed |
| US-20110052655-A1 | METHODS AND VESICLES FOR CONTROLLING PROTOZOA | GENERAL ELECTRIC COMPANY | 2011-03-03 | — | — | US | claimed |
| US-7824557-B2 | Method for controlling microbial biofilm in aqueous systems | GENERAL ELECTRIC COMPANY (US) | 2010-11-02 | — | — | US | claimed |
| EP-2173670-A1 | METHOD FOR CONTROLLING MICROBIAL BIOFILM IN AQUEOUS SYSTEMS | General Electric Company (US) | 2010-04-14 | — | — | EP | claimed |
| WO-2009020694-A1 | METHOD FOR CONTROLLING MICROBIAL BIOFILM IN AQUEOUS SYSTEMS | GENERAL ELECTRIC COMPANY (US) | 2009-02-12 | — | — | WO | claimed |
| US-20090039035-A1 | METHOD FOR CONTROLLING MICROBIAL BIOFLIM IN AQUEOUS SYSTEMS | BL TECHNOLOGIES, INC. | 2009-02-12 | — | — | US | claimed |
| US-20070218522-A1 | METHODS AND COMPOSITIONS FOR RAPIDLY DETECTING AND QUANTIFYING VIABLE LEGIONELLA | PHIGENICS LLC (US) | 2007-09-20 | — | — | US | claimed |
| US-20060211082-A1 | Methods and compositions for rapidly detecting and quantifying viable Legionella | PHIGENICS, LLC | 2006-09-21 | — | — | US | claimed |
| US-6585933-B1 | Method and composition for inhibiting corrosion in aqueous systems | BETZDEARBORN, INC. | 2003-07-01 | — | — | US | claimed |
| EP-1177331-A1 | METHOD AND COMPOSITION FOR INHIBITING CORROSION IN AQUEOUS SYSTEMS | BetzDearborn Inc (US) | 2002-02-06 | — | — | EP | claimed |
| WO-2000066810-A1 | METHOD AND COMPOSITION FOR INHIBITING CORROSION IN AQUEOUS SYSTEMS | BETZDEARBORN INC. (US) | 2000-11-09 | — | — | WO | claimed |
| US-10597314-B2 | Fatty acid biodispersant and methods of use | GENERAL ELECTRIC COMPANY (US) | 2020-03-24 | — | — | US | disclosed |
| WO-2000066810-A1 | METHOD AND COMPOSITION FOR INHIBITING CORROSION IN AQUEOUS SYSTEMS | BETZDEARBORN INC. (US) | 2000-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110052655-A1 | METHODS AND VESICLES FOR CONTROLLING PROTOZOA | CTRL, LIPA, EXOSC9 | MAPT 4289/4885SOS1 3055/4885MAOB 3621/4885 |
| US-20110052656-A1 | METHOD FOR CONTROLLING MICROBIAL BIOFILM IN AQUEOUS SYSTEMS | PGLS, PLTP, PHOSPHO1 | MAPT 3037/4885SOS1 1793/4885MAOB 1879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.